![Frontiers | Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications Frontiers | Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications](https://www.frontiersin.org/files/MyHome%20Article%20Library/790122/790122_Thumb_400.jpg)
Frontiers | Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
![Frontiers | The Molecular Pathophysiology of Psoriatic Arthritis—The Complex Interplay Between Genetic Predisposition, Epigenetics Factors, and the Microbiome Frontiers | The Molecular Pathophysiology of Psoriatic Arthritis—The Complex Interplay Between Genetic Predisposition, Epigenetics Factors, and the Microbiome](https://www.frontiersin.org/files/MyHome%20Article%20Library/662047/662047_Thumb_400.jpg)
Frontiers | The Molecular Pathophysiology of Psoriatic Arthritis—The Complex Interplay Between Genetic Predisposition, Epigenetics Factors, and the Microbiome
![Bone erosion in inflammatory arthritis is attenuated by Trichinella spiralis through inhibiting M1 monocyte/macrophage polarization - ScienceDirect Bone erosion in inflammatory arthritis is attenuated by Trichinella spiralis through inhibiting M1 monocyte/macrophage polarization - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589004222002498-fx1.jpg)
Bone erosion in inflammatory arthritis is attenuated by Trichinella spiralis through inhibiting M1 monocyte/macrophage polarization - ScienceDirect
![Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells - Alivernini - 2018 - Clinical & Experimental Immunology - Wiley Online Library Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells - Alivernini - 2018 - Clinical & Experimental Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e171d2a9-398b-41be-8d40-3da2f7980b53/cei13098-toc-0001-m.jpg?trick=1673156325892)
Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells - Alivernini - 2018 - Clinical & Experimental Immunology - Wiley Online Library
![IJMS | Free Full-Text | Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy IJMS | Free Full-Text | Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy](https://pub.mdpi-res.com/ijms/ijms-23-02366/article_deploy/html/images/ijms-23-02366-g001.png?1645438877)
IJMS | Free Full-Text | Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy
![IJMS | Free Full-Text | Inflammatory Arthritis and Bone Metabolism Regulated by Type 2 Innate and Adaptive Immunity IJMS | Free Full-Text | Inflammatory Arthritis and Bone Metabolism Regulated by Type 2 Innate and Adaptive Immunity](https://www.mdpi.com/ijms/ijms-23-01104/article_deploy/html/images/ijms-23-01104-g001.png)
IJMS | Free Full-Text | Inflammatory Arthritis and Bone Metabolism Regulated by Type 2 Innate and Adaptive Immunity
![Frontiers | Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment Frontiers | Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment](https://www.frontiersin.org/files/Articles/633821/fphar-12-633821-HTML/image_m/fphar-12-633821-g003.jpg)
Frontiers | Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment
![Frontiers | Interferon α Enhances B Cell Activation Associated With FOXM1 Induction: Potential Novel Therapeutic Strategy for Targeting the Plasmablasts of Systemic Lupus Erythematosus Frontiers | Interferon α Enhances B Cell Activation Associated With FOXM1 Induction: Potential Novel Therapeutic Strategy for Targeting the Plasmablasts of Systemic Lupus Erythematosus](https://www.frontiersin.org/files/MyHome%20Article%20Library/498703/498703_Thumb_400.jpg)
Frontiers | Interferon α Enhances B Cell Activation Associated With FOXM1 Induction: Potential Novel Therapeutic Strategy for Targeting the Plasmablasts of Systemic Lupus Erythematosus
![Dynamic control of type I IFN signalling by an integrated network of negative regulators: Trends in Immunology Dynamic control of type I IFN signalling by an integrated network of negative regulators: Trends in Immunology](https://www.cell.com/cms/attachment/2026479355/2045374570/gr1.jpg)
Dynamic control of type I IFN signalling by an integrated network of negative regulators: Trends in Immunology
![Cells | Free Full-Text | Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus Cells | Free Full-Text | Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus](https://pub.mdpi-res.com/cells/cells-08-00963/article_deploy/html/images/cells-08-00963-g001.png?1569567949)
Cells | Free Full-Text | Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus
![Effect of topical interferon-γ gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk/+ mice | Gene Therapy Effect of topical interferon-γ gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk/+ mice | Gene Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fgt.2011.159/MediaObjects/41434_2012_Article_BFgt2011159_Fig1_HTML.jpg)
Effect of topical interferon-γ gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk/+ mice | Gene Therapy
![Exogenous IFN-beta regulates the RANKL-c-Fos-IFN-beta signaling pathway in the collagen antibody-induced arthritis model | Journal of Translational Medicine | Full Text Exogenous IFN-beta regulates the RANKL-c-Fos-IFN-beta signaling pathway in the collagen antibody-induced arthritis model | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-014-0330-y/MediaObjects/12967_2014_Article_330_Fig3_HTML.jpg)